New data from an updated meta-analysis demonstrates that individuals with blood type O have approximately 28% lower risk of developing severe Plasmodium falciparum malaria compared to those with blood types A, B, and AB. This quantifiable difference represents a substantial protective effect confirmed through systematic pooling of multiple research studies.
The meta-analysis employed trial sequential analysis methodology to ensure the robustness of findings across heterogeneous study populations. Type O blood individuals showed a relative risk of 72% compared to the baseline 100% observed in type A individuals, with type B at 98% and type AB at 102%. These consistent findings across diverse geographic and epidemiologic contexts suggest a genuine biological mechanism underlying the protective effect, rather than statistical artifact or population-specific variation.
Such evidence strengthens our understanding of genetic influences on malaria severity and may inform clinical risk assessment strategies.
Read the full article on GMJ Newsroom.
Was this article helpful?
